• Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use
Saturday, July 19, 2025
25 °c
Agartala
enewstime
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    Bumrah should feature in both the remaining Tests: Kumble

    Bumrah should feature in both the remaining Tests: Kumble

    Gill being fired up at Lord’s didn’t have the right effect on his batting returns, says Manjrekar

    Gill being fired up at Lord’s didn’t have the right effect on his batting returns, says Manjrekar

    Jadeja hailed as Team India's MVP after incredible fight at Lord’s

    Jadeja hailed as Team India's MVP after incredible fight at Lord’s

    'Win the toss and bat, put runs on the board': Kaif advises Gill to follow Kohli’s approach  

    'Win the toss and bat, put runs on the board': Kaif advises Gill to follow Kohli’s approach  

    Arsenal sign Olivia Smith for world-record women's transfer fee

    Arsenal sign Olivia Smith for world-record women's transfer fee

    When we played on gravel pitches in Brazil, I'd imagine playing for United: Matheus Cunha

    When we played on gravel pitches in Brazil, I'd imagine playing for United: Matheus Cunha

    I knew with calm and composed approch we can pull off the chase: Deepti Sharma

    I knew with calm and composed approch we can pull off the chase: Deepti Sharma

    'Aussie Ashes line-up is going to be like it is right now', opines Ponting

    'Aussie Ashes line-up is going to be like it is right now', opines Ponting

    Jitesh Sharma to represent Baroda in 2025/26 domestic season after leaving Vidarbha

    Jitesh Sharma to represent Baroda in 2025/26 domestic season after leaving Vidarbha

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
    Bumrah should feature in both the remaining Tests: Kumble

    Bumrah should feature in both the remaining Tests: Kumble

    Gill being fired up at Lord’s didn’t have the right effect on his batting returns, says Manjrekar

    Gill being fired up at Lord’s didn’t have the right effect on his batting returns, says Manjrekar

    Jadeja hailed as Team India's MVP after incredible fight at Lord’s

    Jadeja hailed as Team India's MVP after incredible fight at Lord’s

    'Win the toss and bat, put runs on the board': Kaif advises Gill to follow Kohli’s approach  

    'Win the toss and bat, put runs on the board': Kaif advises Gill to follow Kohli’s approach  

    Arsenal sign Olivia Smith for world-record women's transfer fee

    Arsenal sign Olivia Smith for world-record women's transfer fee

    When we played on gravel pitches in Brazil, I'd imagine playing for United: Matheus Cunha

    When we played on gravel pitches in Brazil, I'd imagine playing for United: Matheus Cunha

    I knew with calm and composed approch we can pull off the chase: Deepti Sharma

    I knew with calm and composed approch we can pull off the chase: Deepti Sharma

    'Aussie Ashes line-up is going to be like it is right now', opines Ponting

    'Aussie Ashes line-up is going to be like it is right now', opines Ponting

    Jitesh Sharma to represent Baroda in 2025/26 domestic season after leaving Vidarbha

    Jitesh Sharma to represent Baroda in 2025/26 domestic season after leaving Vidarbha

  • Business
  • Entertainment
  • Health
  • Features
  • TendersNew
No Result
View All Result
enewstime
  • Home
  • News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders
Home Health

Japanese drugmaker to launch first-ever plant-based Covid vax

ENEWSTIME Desk by ENEWSTIME Desk
October 13, 2021
in Health
30
VIEWS
Share on FacebookShare on Twitter

Japanese pharmaceutical group Mitsubishi Tanabe Pharma is planning to launch the first-ever plant-based Covid-19 vaccine in the world, which will likely to be of low-cost, easier to transport as well as store than the conventional jabs, the media reported.

The vaccine candidate will be developed by the Osaka-based company’s subsidiary Medicago from a plant from the tobacco family by December 2021, the Financial Times reported.

The vaccine technology here is formed with virus-like particles that mimic the target virus and does not actually use a live virus, unlike some of the current vaccines and can thus be deemed relatively safe for humans.

With this new technique, the Japanese pharmaceutical group aims to break into a market which is dominated by major drugmakers Pfizer, Moderna and AstraZeneca.

However, as new strains of the virus continue to emerge, they expect global demand for Covid vaccines to remain strong, the report noted.

“As with seasonal flu, we don’t expect demand [for Covid-19 vaccines] to suddenly disappear and there is still much uncertainty regarding emerging variants,” Toshifumi Tada, head of vaccine business development at Mitsubishi was quoted as saying.

“We believe there is value in expanding options for vaccines,” Tada added.

So far, no plant-based vaccine has been approved for use in humans. But the prospects of such a jab seems viable as plant leaves grow quickly, cutting down the manufacturing process as well as costs.

Medicago’s vaccine can be produced in five to eight weeks, compared to a traditional seasonal flu vaccine that takes about eight months to a year to produce.

Faster production, the report added, will also make it easier to adapt to combat new strains.

Moreover, plant-based vaccines do not need to be deep frozen during transport since Medicago’s vaccine can be stored at temperatures of 2 degrees Celsius to 8 degrees Celsius, the report said.

Medicago is partnering with UK-based GlaxoSmithKline for the vaccine adjuvant, and is analysing phase-3 trial data for the Covid-19 vaccine involving 24,000 subjects in Canada, the US, the UK, Brazil, Argentina and Mexico.

It also began a smaller-scale clinical trial this month in Japan, where it hopes to apply for regulatory approval by March. No serious side-effects have been reported related to its vaccine candidate, according to trial results, the report said.

The company plans to produce about 80 million doses at its plant in North Carolina, US, and aims to raise its annual capacity to 1 billion doses, once its new plant in Quebec City, Canada, begins operations in 2024.

Related Posts

Twin studies report global rise in gastrointestinal cancers among middle-aged adults
Health

Twin studies report global rise in gastrointestinal cancers among middle-aged adults

July 18, 2025
Vietnam issues directive to curb African swine fever outbreaks
Health

Vietnam issues directive to curb African swine fever outbreaks

July 18, 2025
Explained: What is 'chronic venous insufficiency' that Donald Trump is suffering from
Health

Explained: What is 'chronic venous insufficiency' that Donald Trump is suffering from

July 18, 2025
South Africa rolls out mpox vaccination programme to curb spread
Health

South Africa rolls out mpox vaccination programme to curb spread

July 18, 2025
Climate, wildlife key predictors of bird flu outbreaks in Europe: Study
Health

Climate, wildlife key predictors of bird flu outbreaks in Europe: Study

July 18, 2025
Gene essential for vitamin D absorption may boost cancer treatment
Health

Gene essential for vitamin D absorption may boost cancer treatment

July 18, 2025
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT
D-2050 D-2050 D-2050
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT

About us

Enewstime.in is run by an individual – a Journalist by profession of Tripura with the active help of several journos including senior journalists of the State. On top of that, Enewstime.in being a subscriber of IANS news agency, we have plenty of multi-choice topics to offer to our esteemed readers. Enewstime.in is a venture reach global audience from a tiny State Tripura.

Latest News

Twin studies report global rise in gastrointestinal cancers among middle-aged adults

Vietnam issues directive to curb African swine fever outbreaks

Kaveri Kapur opens up about her battle with PCOS & Uranium Poisoning; Admits 'Feeling better now'

Indian stock market ends lower amid selling in banking, IT sectors

Bumrah should feature in both the remaining Tests: Kumble

Explained: What is 'chronic venous insufficiency' that Donald Trump is suffering from

Contact us

19, Old Thana Road. Banamalipur. PO. Agartala. Pin code 799001. Tripura (West), India.

Email: enewstime2017@gmail.com

Wa: 8794548041

  • Contact us
  • Advertising Policy
  • Cookie Policy
  • Disclaimer
  • Privacy Policy
  • Terms of Use

© 2025 Designed & Developed with ❤️ by Provibe Media LLP

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • Home
  • News
    • Northeast
    • National
    • International
    • Tripura News
  • Sports
  • Business
  • Entertainment
  • Health
  • Features
  • Tenders

© 2025 Designed & Developed with ❤️ by Provibe Media LLP